Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 357-359

  Bhattacharya, Sudhindra Mohan ^a   Jha, Ayan ^b  

^a VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF HYGIENE AND PUBLIC HEALTH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77952546644     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.09.025     Document Type: Article

References (22)

1. Elsenbruch S., Hahn S., Kowalsky D., Offner A.H., Schedlows M., Mann K., and Janssen O.E. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 5801-5807
2. McCook J.G., Reame N.E., and Thatcher S.S. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 34 (2005) 12-20
3. Hollinrake E., Abren A., Maifeld M., Van Voorhis B.J., and Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 87 (2007) 1369-1376
4. Spitzer R.L., Williams J.B., Kroenke K., Hornyak R., and McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetric-Gynecologic Study. Am J Obstet Gynecol 183 (2000) 759-769
5. Kroenke K., Spitzer R.L., and Williams J.B.W. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
6. Spitzer R.L., Kroenke K., and Williams J.B.W. Validation and utility of a self-report version of PRIME-MD. JAMA 282 (1999) 1737-1744
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 9 (2004) 41-47
8. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for Type 2 diabetes mellitus and IGT in polycystic ovary syndrome: a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
9. Lewis V. Polycystic ovary syndrome: a diagnostic challenge. Infertil Reprod Med Clin North Am 14 (2003) 497-516
10. Weiner C.L., Primeau M., and Ehrmann D.A. Androgens and mood dysfunction in women: comparison of women with polycystic ovary syndrome to healthy controls. Psychosom Med 66 (2004) 356-362
11. Rasgon N.L., Rao R.C., Hwang S., Altshuler L.L., Elman S., Zuckerbrow-Miller J., and Korenman S.G. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 74 (2003) 299-304
12. Weber B., LeWicka S., Deuschle M., Colla M., and Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 25 (2000) 765-771
13. Baischer W., Koinig G., Hartmann B., Huber J., and Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentration compared to normal controls. Psychoneuroendocrinology 20 (1995) 553-559
14. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
15. Golomb B.A., Tenkanen L., Alikoski T., Niskanen T., Manninen V., Huttunen M., et al. Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol 55 (2002) 767-773
16. Lawlor D.A., Davey Smith G., and Ebrahim S. Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study. BMJ 327 (2003) 1383-1384
17. Lawlor D.A., Ben-Shlomo Y., Ebrahim S., Smith G.D., Stansfeld S.A., Yarnell J.W.G., and Gallacher J.E.J. Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly Prospective Cohort Study. BMJ 26 (2005) 705-706
18. Majewska M.D., Demirgoren S., Spivac C.E., and London E.D. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABA-A receptor. Brain Res 526 (1990) 143-146
19. Majewska M.D., Mienville J.M., and Vicini S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 90 (1988) 279-284
20. Takebavashi M., Kagaya A., Uchitomi Y., Kugaya A., Muraoka M., Yokot N., et al. Plasma dehydroepiandrosterone sulfate in unipolar depression. J Neural Transm 105 (1995) 537-542
21. Murray C.J.L., and Lopez A.D. The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020 vol. 1 (1996), Harvard University Press, Cambridge, MA
22. Douglas G.A., and Bland M.J. Statistics notes: Absence of evidence is not evidence of absence. BMJ 311 7003 (1995) 485